Compositions and methods for treating skin conditions

Details Compositions and methods for treating skin conditions Compositions and methods for treating skin conditions

2008-07-22

2008-07-22

Richter, Johann (Department: 1616)

Drug, bio-affecting and body treating compositions

Inorganic active ingredient containing

Alkali or alkaline earth chloride

C424S682000, C424S687000, C514S880000

Reexamination Certificate

active

10639213

ABSTRACT:
A skin treatment composition containing ionic calcium and a dermatologically acceptable water-soluble, water-miscible or water-based carrier is provided for treating a skin condition in a mammal, such as dry skin, dry scalp, a burn, sunburn, irritation or minor wound. The ionic calcium is preferably present as the water soluble calcium glycerophosphate salt. The composition may be present in a formulation such as bar soap, liquid soap, bath, lotion, cream, gel, or ointment, and may also be useful for stimulating more youthful skin cells and for improving the appearance of the skin. Methods for treating skin conditions and for accelerating cellular repair include topically applying to the skin an effective amount of ionic calcium, preferably as calcium glycerophosphate, and an α-hydroxy acid such as lactic acid.

REFERENCES:
patent: 2118566 (1938-05-01), Miles
patent: 4105783 (1978-08-01), Yu
patent: 4197316 (1980-04-01), Yu
patent: 4363815 (1982-12-01), Yu
patent: 4380549 (1983-04-01), Van Scott
patent: 4560555 (1985-12-01), Snider
patent: 4588590 (1986-05-01), Bernstein
patent: 4743442 (1988-05-01), Raaf et al.
patent: 4772591 (1988-09-01), Meisner
patent: 4797481 (1989-01-01), Garlisi
patent: 4940666 (1990-07-01), Boyce et al.
patent: 5084281 (1992-01-01), Dillon
patent: 5139771 (1992-08-01), Gerstein
patent: 5194253 (1993-03-01), Garrido
patent: 5292655 (1994-03-01), Wille, Jr.
patent: 5593682 (1997-01-01), Papas et al.
patent: 5602183 (1997-02-01), Martin et al.
patent: 5618529 (1997-04-01), Pichierri
patent: 5643586 (1997-07-01), Perricone
patent: 5658956 (1997-08-01), Martin et al.
patent: 5660859 (1997-08-01), Cody et al.
patent: 5665368 (1997-09-01), Lentini et al.
patent: 5716625 (1998-02-01), Hahn et al.
patent: 5776473 (1998-07-01), Perricone et al.
patent: 5830507 (1998-11-01), Armstrong
patent: 5858380 (1999-01-01), Gagnebien
patent: 5866147 (1999-02-01), Ptchelintsev
patent: 5922335 (1999-07-01), Ptchelintsev
patent: 5922359 (1999-07-01), Youssefyeh
patent: 5958436 (1999-09-01), Hahn et al.
patent: 5972321 (1999-10-01), Kligerman et al.
patent: 6013279 (2000-01-01), Klett-Loch
patent: 6063406 (2000-05-01), Hornack
patent: 6080425 (2000-06-01), Miljkovic et al.
patent: 6136328 (2000-10-01), Sebillotte-Arnaud et al.
patent: 6168798 (2001-01-01), O'Halloran et al.
patent: 6184247 (2001-02-01), Schneider
patent: 6277388 (2001-08-01), Chevalier
patent: 6287548 (2001-09-01), Biener
patent: 6294180 (2001-09-01), Demars et al.
patent: 6296856 (2001-10-01), Pineau et al.
patent: 6329343 (2001-12-01), Leung et al.
patent: 6331307 (2001-12-01), Sibillotte-Arnaud et al.
patent: 6599512 (2003-07-01), Burnier
patent: 6830764 (2004-12-01), Inui et al.
patent: 2725901 (1996-04-01), None
Thorel Jean Noel, FR 27225901 A1, 1996.
McKeehan et al., “Epidermal growth factor modulates extracellular Ca2+ requirement for multiplication of normal human skin fibroblasts”;Experimental Cell Research, 123(2):397-400 (Oct. 15, 1979).
Hawley-Nelson et al., “Optimized conditions for the growth of human epidermal cells in culture”;Journal of Investigative Dermatology, 75(2): 176-82 (Aug. 1980).
Dykes et al., “The effect of calcium on the initiation and growth of human epidermal cells”;Archives of Dermatological Research, 273(3-4): 225-31 (1982).
Price et al., “Approaches to enhance proliferation of human epidermal keratinocytes in mass culture”;Journal of the National Cancer Institute, 70(5):853-61 (May 1983).
O'Keefe et al., “Modulation of the epidermal growth factor receptor of human keratinocytes by calcium ion”;Journal of Investigative Dermatology, 81(3): 231-5 (Sep. 1983).
Stoll et al., “Control of the re-epithelialization of skin defects and burns”;Deutsche Zeitschrift fur Mund-, Kiefer-, und Geisichts-Chirurgie, 13(4):260-5 (Jul.-Aug. 1989).
Michel et al., “Fibrin seal in wound healing: effect of thrombin and [Ca2+] on human skin fibroblast growth and collagen production”;Journal of Dermatological Science, 1(5): 325-33 (Sep. 1990).
Davey, et al., “Unusual donor site reactions to calcium alginate dressings”;Burns, 26(4):393-8 (Jun. 2000).
Sun et al., “CLED: A calcium-linked protein associated with early epithelial differentiation”;Experimental Cell Research 259, No. 1 (2000): 96-106 (Aug. 25, 2000).
McNeil et al., “Coping with the inevitable: How cells repair a torn surface membrane”;Nature Cell Biology3, No. 5 (2001): E124-E129 (May 2001).
D'Souza et al., “Ca2+ and BMP-6 signaling regulate E2F during epidermal keratinocyte differentiation”;Journal of Biological Chemistry276, No. 26 (2001: 23531-23538 (Jun. 29, 2001).
Reddy et al., “Plasma membrane repair is mediated by Ca2+−regulated exocytosis of lysosmes”;Cell106, No. 2 (2001): 157-169 (Jul. 27, 2001).
Maziere, et al., “UVA Radiation Stimulates Ceramide Production: Relationship to Oxidative Stress and Potential Role in ERK, JNK, and p38 Activation,”Biochemical and Biophysical Research Communications, 281(2):289-294, 2001.
Rawlings, et al., “Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function,”Archives of Dermatological Research, 288(7):383-390, 1996.
DiMarzio, et al., “Effect of the Lactic Acid BacteriumStreptococcus thermophiluson Ceramide Levels in Human Keratinocytes In Vitro and Statum Corneum In Vivo,”Journal of Investigative Dermatology, 113(1):98-106, 1999.
Watanabe, et al., “Up-regulation of Glucosylceramide Synthase Expression and Activity during Human Keratinocyte Differentiation,”Journal of Biological Chemistry, 273(16):9651-9655, 1998.
Ehlers, et al., “Females have lower skin surface pH than men,”Skin Research and Technology, 7(2):90-94, 2001.
Runeman, et al., “ExperimentalCandida albicansLesions in Healthy Humans: Dependence on Skin pH,”Acta Dermato-Venereologica80(6):421-424, 2000.
Oda, et al., “The Calcium Sensing Receptor and Its Alternatively Spliced Form in Murine Epidermal Differentiation,”Journal of Biological Chemistry, 275(2):1183-1190, 2000.
Schmidt, et al., “Ras-independent Activation of the Raf/MEK/ERK Pathway upon Calcium-induced Differentiation of Keratinocytes,”Journal of Biological Chemistry, 275(52):41011-41017, 2000.
“Skin Care Solutions”, http://styles101.homestead.com/ahas.html.
“Cell-cell adhesion process”,University of Chicago Medical Center Office of Public Affairs Press Release(2000).
Hahn et al.,Drug and Cosmetic Industry, pp. 18-20, 22 (1998).
Tueson et al.,Am. Soc. Derm. Surg.24:641-645 (1998).
“Calcium Glycerophosphate”,National Academy of Sciences: Foods Chemical Codex IVth Ed., p. 60 (1996).
“Calcium Glycerophosphate”,Merck Index 12thEdition, p. 230 Monograph 1644 (1996).

Affiliated with

Also associated with

Rating

Compositions and methods for treating skin conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for treating skin conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating skin conditions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3926566